Literature DB >> 15277915

Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass: a prospective, randomized double-blind trial.

William C Oliver1, Gregory A Nuttall, Thomas A Orszulak, William R Bamlet, Martin D Abel, Mark H Ereth, Hartzell V Schaff.   

Abstract

BACKGROUND: Activation of the inflammatory cascade is thought to account for some of the respiratory dysfunction and prolonged mechanical ventilation associated with cardiopulmonary bypass. The objective of this investigation was to identify whether perioperative steroids or hemofiltration during cardiopulmonary bypass, by their attenuation of inflammation, would reduce duration of mechanical ventilation after cardiac surgery.
METHODS: After Institutional Review Board approval and informed consent, 192 patients scheduled to undergo elective primary coronary artery bypass grafting or valvular replacement or repair were randomized in a double-blind prospective study into three groups. One group (Control) received saline at induction and at 6-h intervals for four doses. Another group (Hemofil) received saline and hemofiltration to obtain 27 ml/kg of hemofiltrate. The final group (Steroid) received 1 g methylprednisolone before anesthesia induction and then 4 mg of dexamethasone at 6-h intervals for four doses. All patients underwent normothermic cardiopulmonary bypass and received propofol for postoperative sedation. Separate two-sample comparisons were performed to compare each experimental group versus the control group using the Wilcoxon rank sum test for continuous variables and Fisher exact test for categorical variables. In all cases, two-tailed P values </= 0.05 were considered statistically significant.
RESULTS: The median time until the patient reached an intermittent mandatory ventilation of 4/min (258.5 versus 385.0 min, respectively; P = 0.02) and tracheal extubation (352.0 versus 518.0 min; P = 0.03) was significantly reduced for group Hemofil but no different for Steroid compared to Control.
CONCLUSIONS: Hemofiltration and steroids are both previously reported to attenuate the inflammatory response but only hemofiltration reduced time to tracheal extubation for adults after cardiopulmonary bypass in this study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277915     DOI: 10.1097/00000542-200408000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

Review 1.  Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.

Authors:  R Clive Landis; Jeremiah R Brown; David Fitzgerald; Donald S Likosky; Linda Shore-Lesserson; Robert A Baker; John W Hammon
Journal:  J Extra Corpor Technol       Date:  2014-09

2.  Efficacy of Xuebijing Injection () on Cardiopulmonary Bypass-Associated Pulmonary Injury: A Prospective, Single-center, Randomized, Double Blinded Trial.

Authors:  Wei Gao; Na Li; Xiao-Guang Cui
Journal:  Chin J Integr Med       Date:  2018-07-31       Impact factor: 1.978

3.  Role of corticosteroids during cardiopulmonary bypass.

Authors:  Judith L Kristeller; Arthur Jankowski; Travis Reinaker
Journal:  Hosp Pharm       Date:  2014-03

4.  Sevoflurane alleviates myocardial ischemia/reperfusion injury via actitation of heat shock protein-70 in patients undergoing double valve replacement surgery.

Authors:  Yue Shan; Kai Xie; Qifu Zhou; Rui He; Zhonghua Chen; Weizhong Feng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  Meta-Analysis: Shouldn't Prophylactic Corticosteroids be Administered During Cardiac Surgery with Cardiopulmonary Bypass?

Authors:  Tianci Chai; Xinghui Zhuang; Mengyue Tian; Xiaojie Yang; Zhihuang Qiu; Shurong Xu; Meiling Cai; Yanjuan Lin; Liangwan Chen
Journal:  Front Surg       Date:  2022-06-01

6.  Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery.

Authors:  Anja Haase-Fielitz; Michael Haase; Rinaldo Bellomo; Gavin Lambert; George Matalanis; David Story; Laurie Doolan; Brian Buxton; Geoff Gutteridge; Friedrich C Luft; Wolf-Hagen Schunck; Duska Dragun
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

7.  Balancing intubation time with postoperative risk in cardiac surgery patients - a retrospective cohort analysis.

Authors:  Katarzyna Kotfis; Aleksandra Szylińska; Mariusz Listewnik; Kacper Lechowicz; Monika Kosiorowska; Sylwester Drożdżal; Mirosław Brykczyński; Iwona Rotter; Maciej Żukowski
Journal:  Ther Clin Risk Manag       Date:  2018-11-05       Impact factor: 2.423

8.  Continuous ultrafiltration during extracorporeal circulation and its effect on lactatemia: A randomized controlled trial.

Authors:  Carlos García-Camacho; Antonio-Jesús Marín-Paz; Carolina Lagares-Franco; María-José Abellán-Hervás; Ana-María Sáinz-Otero
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

9.  Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass.

Authors:  Ben Gibbison; José Carlos Villalobos Lizardi; Karla Isis Avilés Martínez; Daniel P Fudulu; Miguel Angel Medina Andrade; Giordano Pérez-Gaxiola; Alvin Wl Schadenberg; Serban C Stoica; Stafford L Lightman; Gianni D Angelini; Barnaby C Reeves
Journal:  Cochrane Database Syst Rev       Date:  2020-10-12

10.  Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial.

Authors:  Gordana Taleska Stupica; Maja Sostaric; Marija Bozhinovska; Lea Rupert; Zoran Bosnic; Ales Jerin; Alojz Ihan; Tomislav Klokocovnik; Matej Podbregar
Journal:  Cardiovasc Ther       Date:  2020-03-27       Impact factor: 3.023

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.